Belly dancer syndrome improved by withdrawal of droxidopa and amantadine

Belly dancer syndrome improved by withdrawal of droxidopa and amantadine

Key Clinical Message A man hospitalized for cerebral infarction developed drug‐induced belly dancer syndrome, which improved after withdrawal of droxidopa and amantadine. Drugs that modulate dopamine neurotransmission have been reported to be associated with this syndrome. When belly dancer syndrome...

Full description

Bibliographic Details
Main Authors: Mihiro Kaga, Hiroyoshi Ueda, Chika Sunagawa, Masashi Oe, Atsushi Shima, Nobuyasu Matsukawa, Takeshi Ueda
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Clinical Case Reports
Subjects:
abdominal wall
amantadine
dopamine
droxidopa
dyskinesia
movement disorders
Online Access:https://doi.org/10.1002/ccr3.7237

Similar Items

Similar Items